Skip to main content
Zur Rose Group AG logo

Zur Rose Group AG — Investor Relations & Filings

Ticker · ROSE ISIN · CH0042615283 LEI · 50670038OH136R5Z4663 SW Wholesale and retail trade
Open in API
Filings indexed 477 across all filing types
Latest filing 2016-12-06 Legal Proceedings Report
Country CH Switzerland
Listing SW ROSE

About Zur Rose Group AG

https://www.zurrosegroup.com/websites/z…

DocMorris AG, formerly Zur Rose Group AG, is a leading European e-commerce pharmacy. The company provides an online platform for medicines and develops digital health services. Its core strategy involves creating a comprehensive digital health ecosystem that connects patients, doctors, pharmacies, and health insurers on a single platform. The company's vision is to enable individuals to manage their health with a single click, offering integrated care and treatment solutions. Originally founded as a pharmacy wholesaler, it has evolved to focus on the digitalization of healthcare services.

Recent filings

Filing Released Lang Actions
Zur Rose: Entscheid des Verwaltungsgerichts im Kanton Aargau: Elektronische Rezeptubermittlung uneingeschrankt moglich
Legal Proceedings Report Classification · 99% confidence The document is a 'Medienmitteilung' (Media Release) dated December 5, 2016, from Zur Rose Group AG, announcing the outcome of a legal case ('Entscheid des Verwaltungsgerichts des Kantons Aargau') regarding electronic prescription transmission. This is a specific corporate announcement concerning a legal matter. While it relates to legal proceedings, it is structured as a general news release about a court decision affecting operations, rather than a formal legal filing or a comprehensive report. Given the options, 'Legal Proceedings Report' (LTR) is plausible if the focus is the legal outcome, but since it is presented as a standard news release about a specific event (a court ruling), and it doesn't fit the strict definitions of 10-K, ER, or IR, the most appropriate general category for non-standard, specific corporate news that isn't a major financial report or management change is 'Regulatory Filings' (RNS), which serves as a fallback for miscellaneous regulatory/legal news announcements that aren't covered by more specific codes like DIRS or MANG. However, since it explicitly discusses a court decision ('Urteil') and its implications, LTR (Legal Proceedings Report) is a strong candidate, even if it's short. Given the context of a specific legal decision announcement, LTR is more precise than the general RNS fallback. The document length is short (3275 chars), but it is the primary announcement itself, not an announcement *of* an attached report, so RPA is incorrect. I will classify it as LTR due to the explicit mention of a court ruling ('Urteil') on a legal matter.
2016-12-06 German
Zur Rose: Entscheid des Verwaltungsgerichts im Kanton Aargau: Elektronische Rezeptubermittlung uneingeschrankt moglich
Legal Proceedings Report Classification · 99% confidence The document is a 'Medienmitteilung' (Press Release) dated December 5, 2016, detailing a legal decision ('Entscheid des Verwaltungsgerichts des Kantons Aargau') regarding the electronic prescription transmission for Zur Rose. This is an announcement concerning a legal matter or regulatory outcome involving the company. It is not a full financial report (10-K, IR), an earnings release (ER), or a formal proxy/governance document. Since it specifically reports on a significant lawsuit/legal proceeding outcome, the most appropriate category is Legal Proceedings Report (LTR). Although it is a press release, the content is highly specific to legal matters, making LTR a better fit than the general Regulatory Filings (RNS). The document length is short (3240 chars), but it contains the substance of the news, not just an announcement of another report, thus avoiding the RPA classification.
2016-12-05 German
Zur Rose Group vollzieht zweite Tranche der Kapitalerhohung
Share Issue/Capital Change Classification · 99% confidence The document is a 'Medienmitteilung' (Media Release) from Zur Rose Group AG, dated November 9, 2016. The core subject is the completion of the 'zweite Tranche der Kapitalerhöhung' (second tranche of the capital increase) involving CHF 20 million. This explicitly details a financing activity, including the number of shares issued and the resulting change in share capital. This directly aligns with the definition of 'Capital/Financing Update' (CAP). Although it is a news release, the content is substantive financial structuring, not just an announcement of a report, making CAP more specific than RPA or RNS.
2016-11-09 German
Zur Rose Group realise la seconde tranche de l'augmentation de capital
Capital/Financing Update Classification · 99% confidence The document is a press release titled "Zur Rose Group réalise la seconde tranche de l’augmentation de capital" (Zur Rose Group completes the second tranche of the capital increase). It explicitly discusses a capital increase transaction involving the issuance of new shares and the resulting change in share capital and ownership percentage (Corisol holding 22%). This content directly relates to fundraising, financing activities, and capital structure changes. Based on the definitions, this aligns perfectly with the 'Capital/Financing Update' category.
2016-11-09 French
Europaischer Gerichtshof zur deutschen Festpreisbindung: Boni auf rezeptpflichtige Arzneimittel sind zulassig
Legal Proceedings Report Classification · 99% confidence The document is explicitly labeled as an "Ad-hoc" announcement and uses the header "EQS Group-Ad-hoc". It is a short press release format detailing a significant legal development (ECJ ruling on German drug pricing) that is expected to positively impact the company's growth trajectory. It is not a full financial report (like 10-K or IR), nor is it a transcript (CT) or a formal proxy/remuneration document. Since it is a general, material, non-standardized regulatory announcement that doesn't fit the other specific categories (like DIRS, DIV, CAP), the most appropriate classification is the general regulatory filing fallback category, RNS (Regulatory News Service/Announcement). The length (5040 chars) is substantial enough that it's more than just a link announcement, but it is still an announcement of an event/ruling, not the full report itself.
2016-10-19 German
Decision de la Cour de justice de l'Union europeenne sur la fixation de l'Union europeenne sur la fixation de prix imposes en Allemagne:autorisation des bonus sur les medicaments soumis a ordonnance
Legal Proceedings Report Classification · 99% confidence The document is explicitly labeled as an 'Ad-hoc' announcement published on October 19, 2016, under the heading 'Publication d’un communiqué ad hoc en vertu de l’article 53 du RC.' (Publication of an ad hoc announcement pursuant to Article 53 of the RC). It discusses a legal decision (CJEU ruling) impacting the company's business model (pharmacy price fixing/bonuses) and its expected positive influence on growth. This format—a brief, immediate disclosure of material, non-public information via an ad-hoc release—is characteristic of regulatory disclosure requirements, often falling under general regulatory announcements or specific legal/material event disclosures. Since it is not a full report (10-K, IR), an earnings release (ER), or a specific management/board change (MANG), the most appropriate general category for immediate, material regulatory news that doesn't fit elsewhere is Regulatory Filings (RNS), as it is a mandatory, timely disclosure of a significant event. Alternatively, given the focus on a legal matter, 'Legal Proceedings Report (LTR)' could be considered, but RNS is a broader fit for mandatory ad-hoc disclosures of material events.
2016-10-19 French

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.